Evidence map›Paper›PMID 19304853›Full record

ArticleJournal of bacteriology2009

Sialic acid (N-acetyl neuraminic acid) utilization by Bacteroides fragilis requires a novel N-acetyl mannosamine epimerase.

Christopher Brigham, Ruth Caughlan, Rene Gallegos, Mary Beth Dallas, Veronica G Godoy, Michael H Malamy

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 80 citations in OpenAlex.

  1. Discovery of a secretedGut microbes · 2026
    Article
  2. High-throughput analyses ofGut microbes · 2026
    Article
  3. Article
  4. Article
  5. A bidirectionalbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Review
  8. Structural Basis for Tetramerization ofJournal of microbiology and biotechnology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Bacterial Sialic Acid Catabolism at the Host-Microbe Interface.Journal of microbiology (Seoul, Korea) · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Christopher BrighamDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111, USA.
Ruth Caughlan
Rene Gallegos
Mary Beth Dallas
Veronica G Godoy
Michael H Malamy
Tufts University · US

Funding

GENETIC SYSTEMS TO STUDY VIRULENCE IN B FRAGILISR01AI019497 · NIAID · TUFTS UNIVERSITY BOSTON · PI MALAMY, MICHAEL H · 1985 to 2008
$2.6M
Genetic System to Study Virulence in BacteroidesR21AI019497 · NIAID · TUFTS UNIVERSITY BOSTON · PI MALAMY, MICHAEL H · 2003 to 2003
$390k
NIAID NIH HHS AI19497NIAID NIH HHS R01 AI019497NIAID NIH HHS R21 AI019497
6 · The paper itself

Abstract

We characterized the nanLET operon in Bacteroides fragilis, whose products are required for the utilization of the sialic acid N-acetyl neuraminic acid (NANA) as a carbon and energy source. The first gene of the operon is nanL, which codes for an aldolase that cleaves NANA into N-acetyl mannosamine (manNAc) and pyruvate. The next gene, nanE, codes for a manNAc/N-acetylglucosamine (NAG) epimerase, which, intriguingly, possesses more similarity to eukaryotic renin binding proteins than to other bacterial NanE epimerase proteins. Unphosphorylated manNAc is the substrate of NanE, while ATP is a cofactor in the epimerase reaction. The third gene of the operon is nanT, which shows similarity to the major transporter facilitator superfamily and is most likely to be a NANA transporter. Deletion of any of these genes eliminates the ability of B. fragilis to grow on NANA. Although B. fragilis does not normally grow with manNAc as the sole carbon source, we isolated a B. fragilis mutant strain that can grow on this substrate, likely due to a mutation in a NAG transporter; both manNAc transport and NAG transport are affected in this strain. Deletion of the nanE epimerase gene or the rokA hexokinase gene, whose product phosphorylates NAG, in the manNAc-enabled strain abolishes growth on manNAc. Thus, B. fragilis possesses a new pathway of NANA utilization, which we show is also found in other Bacteroides species.

Indexed as

Bacterial ProteinsBacteroides fragilisCarbohydrate EpimerasesHexosaminesModels, BiologicalMutationN-Acetylneuraminic AcidBacterial ProteinsCarbohydrate EpimerasesHexosaminesmannosamineN-Acetylneuraminic Acid

Identifiers

PMID19304853
PMCPMC2681899
OpenAlexW2104699675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.